(HRB) H&R Block - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0936711052
Stock: Tax Preparation, Financial Services, Software, Loans, Debit Cards
Total Rating 39
Risk 74
Buy Signal -0.02
| Risk 5d forecast | |
|---|---|
| Volatility | 31.1% |
| Relative Tail Risk | -1.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.39 |
| Alpha | -43.34 |
| Character TTM | |
|---|---|
| Beta | 0.130 |
| Beta Downside | 0.177 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.54% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: HRB H&R Block March 04, 2026
H&R Block, Inc. (HRB) provides tax preparation services in the US, Canada, and Australia. This includes assisted and DIY options, a common model in the tax services sector.
The company offers various financial products. These include refund transfers, audit support, prepaid debit cards (Emerald Mastercard, Spruce), and short-term loans (Emerald Advance, refund advance). These offerings diversify revenue streams beyond core tax preparation, a strategy used by many financial service providers.
HRB also provides small business financial solutions, such as payment processing, payroll, and bookkeeping. This expands their market beyond individual taxpayers.
Service delivery channels include company-owned and franchised retail offices, online platforms, mobile apps, and desktop software. This multi-channel approach is standard for large service organizations.
To learn more about HRBs financial performance and competitive landscape, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 613.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA -7.45 > 1.0 |
| NWC/Revenue: 4.93% < 20% (prev -7.79%; Δ 12.72% < -1%) |
| CFO/TA 0.21 > 3% & CFO 605.7m > Net Income 613.8m |
| Net Debt (2.87b) to EBITDA (989.4m): 2.90 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (126.6m) vs 12m ago -6.64% < -2% |
| Gross Margin: 54.68% > 18% (prev 0.44%; Δ 5423 % > 0.5%) |
| Asset Turnover: 134.4% > 50% (prev 133.5%; Δ 0.88% > 0%) |
| Interest Coverage Ratio: 10.72 > 6 (EBITDA TTM 989.4m / Interest Expense TTM 81.3m) |
Altman Z'' 1.22
| A: 0.06 (Total Current Assets 841.8m - Total Current Liabilities 654.8m) / Total Assets 2.93b |
| B: -0.31 (Retained Earnings -904.8m / Total Assets 2.93b) |
| C: 0.31 (EBIT TTM 871.7m / Avg Total Assets 2.82b) |
| D: -0.25 (Book Value of Equity -954.6m / Total Liabilities 3.75b) |
| Altman-Z'' Score: 1.22 = BB |
Beneish M -2.88
| DSRI: 1.05 (Receivables 352.5m/321.2m, Revenue 3.79b/3.62b) |
| GMI: 0.81 (GM 54.68% / 44.31%) |
| AQI: 1.41 (AQ_t 0.71 / AQ_t-1 0.51) |
| SGI: 1.05 (Revenue 3.79b / 3.62b) |
| TATA: 0.00 (NI 613.8m - CFO 605.7m) / TA 2.93b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of HRB shares?
As of March 07, 2026, the stock is trading at USD 31.67 with a total of 1,548,891 shares traded.
Over the past week, the price has changed by +1.93%, over one month by -4.78%, over three months by -23.78% and over the past year by -37.01%.
Over the past week, the price has changed by +1.93%, over one month by -4.78%, over three months by -23.78% and over the past year by -37.01%.
Is HRB a buy, sell or hold?
H&R Block has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold HRB.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | 29.5% |
| Analysts Target Price | 41 | 29.5% |
HRB Fundamental Data Overview March 05, 2026
P/E Trailing = 7.2248
P/E Forward = 5.767
P/S = 1.0534
P/B = 74.0056
P/EG = 0.4614
Revenue TTM = 3.79b USD
EBIT TTM = 871.7m USD
EBITDA TTM = 989.4m USD
Long Term Debt = 2.44b USD (from longTermDebt, last quarter)
Short Term Debt = 200.7m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.87b USD (from netDebt column, last quarter)
Enterprise Value = 6.88b USD (3.99b + Debt 3.23b - CCE 349.2m)
Interest Coverage Ratio = 10.72 (Ebit TTM 871.7m / Interest Expense TTM 81.3m)
EV/FCF = 13.12x (Enterprise Value 6.88b / FCF TTM 524.1m)
FCF Yield = 7.62% (FCF TTM 524.1m / Enterprise Value 6.88b)
FCF Margin = 13.83% (FCF TTM 524.1m / Revenue TTM 3.79b)
Net Margin = 16.19% (Net Income TTM 613.8m / Revenue TTM 3.79b)
Gross Margin = 54.68% ((Revenue TTM 3.79b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 84.91% (prev 8.79%)
Tobins Q-Ratio = 2.35 (Enterprise Value 6.88b / Total Assets 2.93b)
Interest Expense / Debt = 0.72% (Interest Expense 23.4m / Debt 3.23b)
Taxrate = 22.01% (172.0m / 781.4m)
NOPAT = 679.9m (EBIT 871.7m * (1 - 22.01%))
Current Ratio = 1.29 (Total Current Assets 841.8m / Total Current Liabilities 654.8m)
Debt / Equity = -3.93 (negative equity) (Debt 3.23b / totalStockholderEquity, last quarter -823.1m)
Debt / EBITDA = 2.90 (Net Debt 2.87b / EBITDA 989.4m)
Debt / FCF = 5.47 (Net Debt 2.87b / FCF TTM 524.1m)
Total Stockholder Equity = -369.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.76% (Net Income 613.8m / Total Assets 2.93b)
RoE = -166.1% (negative equity) (Net Income TTM 613.8m / Total Stockholder Equity -369.5m)
RoCE = 42.19% (EBIT 871.7m / Capital Employed (Equity -369.5m + L.T.Debt 2.44b))
RoIC = 47.89% (NOPAT 679.9m / Invested Capital 1.42b)
WACC = 3.94% (E(3.99b)/V(7.23b) * Re(6.67%) + D(3.23b)/V(7.23b) * Rd(0.72%) * (1-Tc(0.22)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.71%
[DCF] Terminal Value 85.45% ; FCFF base≈589.4m ; Y1≈541.8m ; Y5≈484.9m
[DCF] Fair Price = 92.67 (EV 14.61b - Net Debt 2.87b = Equity 11.75b / Shares 126.8m; r=5.90% [WACC]; 5y FCF grow -10.12% → 2.90% )
EPS Correlation: -21.94 | EPS CAGR: -61.05% | SUE: -0.03 | # QB: 0
Revenue Correlation: -18.88 | Revenue CAGR: -46.40% | SUE: 0.60 | # QB: 0
EPS current Year (2026-06-30): EPS=5.00 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=5.58 | Chg7d=+0.110 | Chg30d=+0.110 | Revisions Net=+2 | Growth EPS=+11.6% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -5.9% (Discount Rate 7.9% - Earnings Yield 13.8%)
[Growth] Growth Spread = +9.1% (Analyst 3.2% - Implied -5.9%)
P/E Forward = 5.767
P/S = 1.0534
P/B = 74.0056
P/EG = 0.4614
Revenue TTM = 3.79b USD
EBIT TTM = 871.7m USD
EBITDA TTM = 989.4m USD
Long Term Debt = 2.44b USD (from longTermDebt, last quarter)
Short Term Debt = 200.7m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.87b USD (from netDebt column, last quarter)
Enterprise Value = 6.88b USD (3.99b + Debt 3.23b - CCE 349.2m)
Interest Coverage Ratio = 10.72 (Ebit TTM 871.7m / Interest Expense TTM 81.3m)
EV/FCF = 13.12x (Enterprise Value 6.88b / FCF TTM 524.1m)
FCF Yield = 7.62% (FCF TTM 524.1m / Enterprise Value 6.88b)
FCF Margin = 13.83% (FCF TTM 524.1m / Revenue TTM 3.79b)
Net Margin = 16.19% (Net Income TTM 613.8m / Revenue TTM 3.79b)
Gross Margin = 54.68% ((Revenue TTM 3.79b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 84.91% (prev 8.79%)
Tobins Q-Ratio = 2.35 (Enterprise Value 6.88b / Total Assets 2.93b)
Interest Expense / Debt = 0.72% (Interest Expense 23.4m / Debt 3.23b)
Taxrate = 22.01% (172.0m / 781.4m)
NOPAT = 679.9m (EBIT 871.7m * (1 - 22.01%))
Current Ratio = 1.29 (Total Current Assets 841.8m / Total Current Liabilities 654.8m)
Debt / Equity = -3.93 (negative equity) (Debt 3.23b / totalStockholderEquity, last quarter -823.1m)
Debt / EBITDA = 2.90 (Net Debt 2.87b / EBITDA 989.4m)
Debt / FCF = 5.47 (Net Debt 2.87b / FCF TTM 524.1m)
Total Stockholder Equity = -369.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.76% (Net Income 613.8m / Total Assets 2.93b)
RoE = -166.1% (negative equity) (Net Income TTM 613.8m / Total Stockholder Equity -369.5m)
RoCE = 42.19% (EBIT 871.7m / Capital Employed (Equity -369.5m + L.T.Debt 2.44b))
RoIC = 47.89% (NOPAT 679.9m / Invested Capital 1.42b)
WACC = 3.94% (E(3.99b)/V(7.23b) * Re(6.67%) + D(3.23b)/V(7.23b) * Rd(0.72%) * (1-Tc(0.22)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.71%
[DCF] Terminal Value 85.45% ; FCFF base≈589.4m ; Y1≈541.8m ; Y5≈484.9m
[DCF] Fair Price = 92.67 (EV 14.61b - Net Debt 2.87b = Equity 11.75b / Shares 126.8m; r=5.90% [WACC]; 5y FCF grow -10.12% → 2.90% )
EPS Correlation: -21.94 | EPS CAGR: -61.05% | SUE: -0.03 | # QB: 0
Revenue Correlation: -18.88 | Revenue CAGR: -46.40% | SUE: 0.60 | # QB: 0
EPS current Year (2026-06-30): EPS=5.00 | Chg7d=+0.050 | Chg30d=+0.050 | Revisions Net=+2 | Growth EPS=+7.3% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=5.58 | Chg7d=+0.110 | Chg30d=+0.110 | Revisions Net=+2 | Growth EPS=+11.6% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -5.9% (Discount Rate 7.9% - Earnings Yield 13.8%)
[Growth] Growth Spread = +9.1% (Analyst 3.2% - Implied -5.9%)